Business Context and Reporting Period
Company: Wellchange Holdings Company Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of August 2026
Event: Completion of a best-efforts private placement offering of Class A ordinary shares.
Key Financial Metrics
This filing reports on a capital raise event rather than operational financial performance. Specific metrics include:
- Gross Proceeds: $7.5 million
- Shares Issued: 50,000,000 Class A ordinary shares
- Offering Price: $0.15 per share
- Placement Agent Fees: 6.0% cash fee plus 1.0% non-accountable expense allowance (7.0% total of gross proceeds)
- Reimbursable Expenses: Up to $100,000 for out-of-pocket costs
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the increase in equity capital and share count resulting from the Offering closed on August 31, 2026. The Company entered into a Securities Purchase Agreement on August 28, 2026, to sell the shares to several investors. This transaction follows the effectiveness of a post-effective amendment to the Company's Form F-1 registration statement on August 27, 2026.
Guidance, Outlook, and Use of Proceeds
Management intends to allocate the net proceeds from the Offering as follows:
- 30%: Business expansion and operational scaling
- 20%: Sales and marketing activities
- 20%: Strategic investments and treasury management
- 20%: Working capital and other general corporate purposes
- 10%: Research and development and software platform enhancement
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers, noting that actual results may differ materially due to risks discussed in the Form F-1. The Company granted Prime Number Capital, LLC a nine-month right of first refusal for future equity or debt offerings.
Investor Verification Checklist
- Verify the final net proceeds after deducting the 7.0% placement fees and up to $100,000 in reimbursable expenses.
- Review the full text of the Placement Agency Agreement (Exhibit 10.1) for the specific terms of the right of first refusal granted to Prime Number Capital, LLC.
- Confirm the dilution impact of the 50,000,000 new shares on existing shareholders.
- Examine the Form F-1 (Registration No. 333-297294) for detailed risk factors and historical financial data not included in this 6-K.